You are here

Title: Development of Novel Anticancer Agent to potentiate sensitivity to anti-estrogen therapy PoP: 09/19/2014 to 09/18/2016

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N44CO140040
Agency Tracking Number: N44CO140040
Amount: $1,478,552.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: NCI
Solicitation Number: N/A
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
A AND G PHARMACEUTICAL, INC.
COLUMBIA, MD 21045-2006
United States
DUNS: 9
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 GINETTE SERRERO
 (410) 884-4100
 GSERRERO@AGPHARMA.COM
Business Contact
 GINETTE SERRERO
Phone: (410) 884-4100
Email: GSERRERO@AGPHARMA.COM
Research Institution
 Stub
Abstract

Not Available

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government